18 April 2023
Latham & Watkins Advises Prometheus Biosciences in US$10.8 Billion Acquisition by Merck
Advising firms
Deal team
21 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Daniel Rees Lead | Latham & Watkins LLP | Partner | corporate | Orange County |
| Matthew Bush | Latham & Watkins LLP | Partner | corporate | San Diego |
| Cheston Larson | Latham & Watkins LLP | Partner | corporate | San Diego |
| Brian Umanoff | Latham & Watkins LLP | Associate | corporate | Not stated |
| Abby Timmons | Latham & Watkins LLP | Associate | corporate | Not stated |
| Jack McKay | Latham & Watkins LLP | Associate | corporate | Not stated |
| Jack Vanderford | Latham & Watkins LLP | Associate | corporate | Not stated |
| Holly Bauer | Latham & Watkins LLP | Partner | benefits and compensation | San Diego |
| Laura Szarmach | Latham & Watkins LLP | Counsel | benefits and compensation | Washington, D.C. |
| Julie Voorhes | Latham & Watkins LLP | Associate | benefits and compensation | Not stated |
| Ben Haas | Latham & Watkins LLP | Partner | regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Partner | regulatory | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Counsel | regulatory | Washington, D.C. |
| Josh Holian | Latham & Watkins LLP | Partner | antitrust | Bay Area |
| Kevin Wu | Latham & Watkins LLP | Associate | antitrust | Not stated |
| Chris Hazuka | Latham & Watkins LLP | Partner | intellectual property | Bay Area |
| Robert Yeh | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Kristina Funahashi | Latham & Watkins LLP | Associate | intellectual property | Not stated |
| Samuel Weiner | Latham & Watkins LLP | Partner | tax | Century City |
| Seung (Sam) Yang | Latham & Watkins LLP | Associate | tax | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy | Bay Area |
Stated terms
- Stated value
- USD 10.8bn (US$10.8 billion)
- What the figure measures
- Total transaction value
- Client
- Prometheus Biosciences, Inc.Sell-side
- Counterparties
- Merck (Buy-side)